Abiopharma

Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting

Management and officers – staffing as of 19.4.26

Ceased to serve as a director – Gideon Hartstein as of 19.4.26

Notice of general meeting for 24.5.26 - voting form

PYPL Deadline: Rosen Law Firm Urges PayPal Holdings, Inc. (NASDAQ: PYPL) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

QXO to Acquire TopBuild for $17 Billion

Holdings of interested parties/officers as of 31.3.26

Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712

Nektar to Hold Conference Call to Discuss 52-Week Topline Results from the 16-Week Extension Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on April 20, 2026

Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712